#Q4 #GLAXOSMITHKLINEPHARMACEUTICALS LTD. #Pharma #Strong πͺ
π PAT(YoY) Increased by 284.28% to 358.15 vs 93.2(in Crores)
π EPS(YoY) Increased by 284.36% to 21.14 vs 5.5
π’ Dividend Announcement : Rs 30.
π PAT(YoY) Increased by 284.28% to 358.15 vs 93.2(in Crores)
π EPS(YoY) Increased by 284.36% to 21.14 vs 5.5
π’ Dividend Announcement : Rs 30.
Amrutanjan Healthcare #Q4FY21 #Strong πͺ
YoY
REVENUE: 97 cr vs 62 cr ( 56% up)
PBT: 14 cr vs 11 cs (27% up)
EPS: 3.5 vs 2.7
QoQ
REVENUE: 97 cr vs 103 cr (6% down)
PBT: 14 cr vs 28 cs (50% down)
EPS: 3.5 vs 7.18
FY21 VS FY20
REVENUE: 344 cr vs 270 cr(27% up)
PBT : 82 cr vs 34 cr (141% up)
EPS: 20.94 vs 8.58
OCF: 90 cr vs 18 cr
DIVIDEND: 2.6 Rs
YoY
REVENUE: 97 cr vs 62 cr ( 56% up)
PBT: 14 cr vs 11 cs (27% up)
EPS: 3.5 vs 2.7
QoQ
REVENUE: 97 cr vs 103 cr (6% down)
PBT: 14 cr vs 28 cs (50% down)
EPS: 3.5 vs 7.18
FY21 VS FY20
REVENUE: 344 cr vs 270 cr(27% up)
PBT : 82 cr vs 34 cr (141% up)
EPS: 20.94 vs 8.58
OCF: 90 cr vs 18 cr
DIVIDEND: 2.6 Rs